↓ Skip to main content

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin

Overview of attention for article published in Cardiovascular Diabetology, February 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
Published in
Cardiovascular Diabetology, February 2021
DOI 10.1186/s12933-021-01250-5
Pubmed ID
Authors

Craig I. Coleman, Olivia S. Costa, Christopher W. Brescia, Burcu Vardar, Khaled Abdelgawwad, Nitesh Sood

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 11%
Student > Master 5 11%
Student > Doctoral Student 2 4%
Unspecified 2 4%
Student > Ph. D. Student 2 4%
Other 6 13%
Unknown 24 52%
Readers by discipline Count As %
Medicine and Dentistry 12 26%
Nursing and Health Professions 4 9%
Unspecified 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Economics, Econometrics and Finance 1 2%
Other 1 2%
Unknown 25 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2021.
All research outputs
#13,424,752
of 23,381,576 outputs
Outputs from Cardiovascular Diabetology
#657
of 1,436 outputs
Outputs of similar age
#195,009
of 418,164 outputs
Outputs of similar age from Cardiovascular Diabetology
#16
of 42 outputs
Altmetric has tracked 23,381,576 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,436 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,164 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.